Table 1. Clinical characteristics of the... | American Society of Hematology

Table 1.

Clinical characteristics of the AML patients

Patient	Age, y/sex	FAB type	WBCs, × 10⁹/L (% blasts)^*	Cytogenetics from BM (% abnormal)	FISH probe^†
1	21/M	M1	252 (90)	46,XY, add(6)(p23), t(6;11)(q27;23) (100)	11q23 MLL
2	64/F	M4	151 (75)	46,XX	NA
3	48/M	M5a	72 (53)	46,XY	NA
4	58/F	M4	370 (46)	47,XY,+13 (38)	13q14
5	60/F	M5a	47 (92)	46,XX	NA
6	33/F	M4	88 (30)	46,XX	NA
7	73/F	M2	33 (92)	46,XX	NA

Patient	Age, y/sex	FAB type	WBCs, × 10⁹/L (% blasts)^*	Cytogenetics from BM (% abnormal)	FISH probe^†
1	21/M	M1	252 (90)	46,XY, add(6)(p23), t(6;11)(q27;23) (100)	11q23 MLL
2	64/F	M4	151 (75)	46,XX	NA
3	48/M	M5a	72 (53)	46,XY	NA
4	58/F	M4	370 (46)	47,XY,+13 (38)	13q14
5	60/F	M5a	47 (92)	46,XX	NA
6	33/F	M4	88 (30)	46,XX	NA
7	73/F	M2	33 (92)	46,XX	NA

NA indicates not applicable.

WBCs indicates total PB white blood cell count at diagnosis.

The probes used are described in “Patients, materials, and methods.”